TipRanks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market
STRO
Sutro Biopharma
RESEARCH TOOLSreports
Want to see STRO full AI Analyst Report?

Sutro Biopharma (STRO) Stock News & Sentiment

746 Followers
Sutro’s New Phase 1 Cancer Study Puts STRO-006 in the Spotlight
Premium
Company Announcements
Sutro’s New Phase 1 Cancer Study Puts STRO-006 in the Spotlight
8d ago
STRO
Analyst Maintains Buy on Sutro Biopharma, Reaffirming $50 Price Target on Differentiated ADC Platform
Premium
Ratings
Analyst Maintains Buy on Sutro Biopharma, Reaffirming $50 Price Target on Differentiated ADC Platform
16d ago
STRO
Maldonado Reiterates Buy on Sutro, Sees STRO-004 Data as Proof-of-Concept and Keeps $50 Price Target Unchanged
Premium
Ratings
Maldonado Reiterates Buy on Sutro, Sees STRO-004 Data as Proof-of-Concept and Keeps $50 Price Target Unchanged
3M ago
STRO
Sutro Biopharma: Encouraging STRO-004 Early Data and Solid Execution Support Unchanged $54 Price Target and Buy Rating
Premium
Ratings
Sutro Biopharma: Encouraging STRO-004 Early Data and Solid Execution Support Unchanged $54 Price Target and Buy Rating
3M ago
STRO
Sutro Biopharma Q2 Results Highlight Advancing ADC Pipeline
Premium
Company Announcements
Sutro Biopharma Q2 Results Highlight Advancing ADC Pipeline
3M ago
8K
STRO
Sutro Biopharma (STRO) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Sutro Biopharma (STRO) Q2 Earnings Cheat Sheet
3M ago
STRO
Sutro Biopharma Shareholders Back Board, Pay and Auditor
Premium
Company Announcements
Sutro Biopharma Shareholders Back Board, Pay and Auditor
5M ago
8K
STRO
More STRO News >

STRO News on the Web

Analysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Lucid Diagnostics (LUCD) and MIRA Pharmaceuticals, Inc. (MIRA)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)
TipRanks News
Bullish
Velan Capital Investment Management LP Expands Edesa Biotech Inc (EDSA) Stake
GuruFocus News
Neutral
Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)
TipRanks News
Neutral
Maldonado Reiterates Buy on Sutro, Sees STRO-004 Data as Proof-of-Concept and Keeps $50 Price Target Unchanged
TipRanks News
Bullish
Sutro Announces Encouraging Early Clinical Activity From STRO-004 Phase 1 Study; Stock Down
rttnews
Neutral
Barclays Sticks to Its Buy Rating for Sutro Biopharma (STRO)
TipRanks News
Bullish
Sutro Biopharma Shareholders Back Board, Pay and Auditor
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
STRO
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is STRO’s Media Buzz Sentiment?
1 articles about STRO were published this week. In an average week, 2.5 articles are published.
    What is STRO’s weekly average amount of articles?
    In an average week, 2.5 articles about STRO are published.
      What is STRO’s News Sentiment?
      100% of articles about STRO were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week